April 01, 2025FinancialTerumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
April 01, 2025CorporateTerumo unveils "Our Promise," the long-term direction to be pursued by the entire groupThe company also launches a group brand video and visuals that express its unwavering commitment to improving patients’ lives
March 31, 2025CorporateTerumo opens new R&D center in the U.S. to strengthen global innovation capabilities
Stories Our Technologies Introducing the Terumo Group’s R&D and production engineering initiatives. #12 Personalized Treatment of Liver Cancer Using Microscopic Radioactive Beads #11 Keeping Hope Alive: The Story of the Terumo Implantable Left Ventricular Assist System #10 "Hybrid" Graft Technologies to Support the Evolution of Aortic Treatment #09 Delivering Efficiency and Quality to Cell Therapy Manufacturing #08 Improving Interventional Treatment Quality Pursuing Intravascular Imaging Technology #07 ICT Healthcare Evolution and the State of Pharmaceutical Infusion Systems #06 Terumo Bay Area Innovation Lab A place to create new value #05 Creating Core Technologies to Contribute into the Future #04 Integrating Technologies to Give Diabetes Patients Lifestyle Freedom #03 Technology that Meets Patients’ Medication Needs with Safety and Certainty #02 Continuously Innovating First-in-class Technology to Support Cardiovascular Surgery #01 Intervention through the Wrist Thirty Years of Evolution; More to Come